The Galen and Hilary Weston Foundation (previously The Selfridges Group Foundation) funds research and support that will transform the landscape of treatment and care for those affected by neurodegenerative diseases of ageing.
To cultivate a rich ecosystem of people and projects that will transform the landscape of treatment and care for those affected by neurodegenerative diseases of ageing.
To invest in pioneering research and support that delivers life-changing outcomes for people living with these diseases.
We are goal-driven, supporting projects that deliver tangible outcomes.
We seek out talented individuals and empower them to solve big problems through new approaches.
We invest in high-quality assessment of every proposal and prioritise projects that are rooted in proven expertise and sound methodology.
We share knowledge and bring the brightest minds together to advance progress in the field.
Providing catalyst funding for high-risk, high-reward translational research focused on biomarkers and symptom-focused treatments for Dementia with Lewy Bodies (DLB) and Parkinson’s Disease Dementia (PDD).
Image credit: Dementia Research Centre, Institute of Neurology, UCL